Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
28 02 2021
Historique:
received: 21 08 2020
revised: 20 11 2020
accepted: 23 11 2020
pubmed: 30 11 2020
medline: 21 5 2021
entrez: 29 11 2020
Statut: ppublish

Résumé

Aberrant activation of the Hedgehog (Hh) pathway leads to the development of several tumors, including medulloblastoma (MB), the most common pediatric brain malignancy. Hh inhibitors acting on GLI1, the final effector of Hh signaling, offer a valuable opportunity to overcome the pitfalls of the existing therapies to treat Hh-driven cancers. In this study, the toxicity, delivery, biodistribution, and anticancer efficacy of Glabrescione B (GlaB), a selective GLI1 inhibitor, were investigated in preclinical models of Hh-dependent MB. To overcome its poor water solubility, GlaB was formulated with a self-assembling amphiphilic polymer forming micelles, called mPEG

Identifiants

pubmed: 33249196
pii: S0304-3835(20)30626-1
doi: 10.1016/j.canlet.2020.11.028
pii:
doi:

Substances chimiques

Atoh1 protein, mouse 0
Basic Helix-Loop-Helix Transcription Factors 0
Cholanes 0
Chromones 0
Drug Carriers 0
Hedgehog Proteins 0
Micelles 0
Shh protein, mouse 0
glabrescione B 0
Polyethylene Glycols 3WJQ0SDW1A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-231

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Paola Infante (P)

Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Roma, Italy.

Alessio Malfanti (A)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Deborah Quaglio (D)

Department of Chemistry and Technology of Drugs, University La Sapienza, Roma, Italy.

Silvia Balducci (S)

Department of Chemistry and Technology of Drugs, University La Sapienza, Roma, Italy.

Sara De Martin (S)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Francesca Bufalieri (F)

Department of Molecular Medicine, University La Sapienza, Roma, Italy.

Francesca Mastrotto (F)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Irene Basili (I)

Department of Molecular Medicine, University La Sapienza, Roma, Italy.

Mariangela Garofalo (M)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Ludovica Lospinoso Severini (L)

Department of Molecular Medicine, University La Sapienza, Roma, Italy.

Mattia Mori (M)

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.

Isabella Manni (I)

UOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, Roma, Italy.

Marta Moretti (M)

Department of Experimental Medicine, University La Sapienza, Roma, Italy.

Carmine Nicoletti (C)

DAHFMO-Unit of Histology and Medical Embryology, University La Sapienza, Roma, Italy; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, University La Sapienza, Roma, Italy.

Giulia Piaggio (G)

UOSD SAFU, Department of Research, Diagnosis and Innovative Technologies, IRCCS-Regina Elena National Cancer Institute, Roma, Italy.

Paolo Caliceti (P)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.

Bruno Botta (B)

Department of Chemistry and Technology of Drugs, University La Sapienza, Roma, Italy.

Francesca Ghirga (F)

Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Roma, Italy. Electronic address: francesca.ghirga@iit.it.

Stefano Salmaso (S)

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy. Electronic address: stefano.salmaso@unipd.it.

Lucia Di Marcotullio (L)

Department of Molecular Medicine, University La Sapienza, Roma, Italy; Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Department of Molecular Medicine, University La Sapienza, Roma, Italy. Electronic address: lucia.dimarcotullio@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH